They demonstrated that MSC and CD34+ HSC transplantation were the most successful and effective approaches in patients with insulin-dependent diabetes as they resulted in occurrence of insulin-free period in 20–60% of the patients and 7–50% reduction in their insulin requirement [16]. The gene discussed is CD34; the disease is type 1 diabetes mellitus.